The court, which has exclusive jurisdiction over patent appeals, on Tuesday rejected Apple’s motion to expedite the date of oral argument in the case. The tech giant’s motion was opposed by both the ITC and Masimo Corp., a medical device company that convinced the trade agency last year that Apple infringed claims from two of its blood-oxygen sensor patents.
Apple continues to import and sell its popular watches without the blood-oxygen function, ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.